Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Ewing's sarcoma and related subtypes of primitive neuroectodermal tumours share a recurrent and specific t(11;22) (q24;q12) chromosome translocation, the breakpoints of which have recently been cloned. Phylogenetically conserved restriction fragments in the vicinity of EWSR1 and EWSR2, the genomic regions where the breakpoints of chromosome 22 and chromosome 11 are, respectively, have allowed identification of transcribed sequences from these regions and has indicated that a hybrid transcript might be generated by the translocation. Here we use these fragments to screen human complementary DNA libraries to show that the translocation alters the open reading frame of an expressed gene on chromosome 22 gene by substituting a sequence encoding a putative RNA-binding domain for that of the DNA-binding domain of the human homologue of murine Fli-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ewing’s sarcoma, a common pediatric cancer, is invariably associated with ETS gene translocations (182) that result in a fusion oncogene consisting of the 5′ end of EWS and the 3′ end of FLI1, or less frequently ERG, ETV1, ETV4, or FEV (Figure 1a) (183, 184).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [183]
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
RNA recognition: towards identifying determinants of specificity
Kenan, D. J., Query, C. C., & Keene, J. D. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90088-d · Cited by 730
RNA-binding proteins as developmental regulators.
Bandziulis, R. J., Swanson, M. S., & Dreyfuss, G. (1989) · Genes & Development · doi:10.1101/gad.3.4.431 · Cited by 644
Turc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J. P., Olschwang, S., Philip, I., Berger, M. P., et al. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90285-3 · Cited by 466
Self-citationBen-David, Y., Giddens, E. B., Letwin, K., & Bernstein, A. (1991) · Genes & Development · doi:10.1101/gad.5.6.908 · Cited by 403
Chromosome Translocation in Peripheral Neuroepithelioma
Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Douglass, E. C., & Israel, M. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110907 · Cited by 399
Chromosomal Translocations in Ewing's Sarcoma
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090817 · Cited by 330
Corden, J. L. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90236-5 · Cited by 327
Turc-Carel, C., Philip, I., Berger, M.-P., Philip, T., & Lenoir, G. M. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90002-5 · Cited by 291
Research works printed but not linked: 8
- Aurias, A., Rimbaut, C., Buffe, C., Dubousset, J. & Mazabraud, A. N. Engl. J. Med. 309, 496–497 (1983).
- Turc-Carel, C., Philip, I., Berge, R. M. P., Philip, T. & Lenoir, G. M. N. Engl. J. Med. 309, 497–498 (1983).
- De Chadarevian, J. P., Vekemans, M. & Seemayer, T. A. N. Engl. J. Med. 311, 1702–1703 (1984).
- Cavazzana, A. O. et al. Adv. Neuroblastoma Res. 2, 463–473 (1988).
- Zucman, J. et al. Genes Chrom. Cancer (in the press).
- Douglass, E. C., Valentine, M., Green, A. A., Hayes, F. A. & Thompson, E. I. J. natn. Cancer Inst. 77, 1211–1213 (1986).
- Watson, D. K., Ascione, R. & Papas, T. S. Crit. Rev. Oncogenesis 1, 409–436 (1990).
- Rouleau, G. A. et al. Am. J. hum. Genet. 46, 323–328 (1990).
Cited by
Items 601–700 of 1,002
Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors
Tuna, M., Amos, C. I., & Mills, G. B. (2019) · Oncotarget · doi:10.18632/oncotarget.26777 · Cited by 59
Schoolmeester, J. K., Folpe, A. L., Nair, A., Halling, K. C., Sutton, B. C., Landers, E. E., Karnezis, A. N., Dickson, B. C., Nucci, M. R., & Kolin, D. L. (2021) · Modern Pathology · doi:10.1038/s41379-021-00843-5 · Cited by 47
Moore, D. D., & Haydon, R. C. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-07323-1_5 · Cited by 47
Fujimura, Y., Siddique, H., Lee, L., Rao, V. N., & Reddy, E. S. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204684 · Cited by 50
“In these tumors, the EWS gene is fused to various transcriptional factors like ETS family members Fli-1 (Ben-David et al., 1991; Prasad et al., 1992; Delattre et al., 1992), erg (Rao et al., 1987; Reddy et al., 1987; Sorensen et al., 1994), ETV1 (Jeon et al., 1995), E1A-F (Kaneko et al., 1996;…”
BackgroundA Benign Vascular Tumor With a New Fusion Gene: EWSR1-NFATC1 in Hemangioma of the Bone
Arbajian, E., Magnusson, L., Brosjö, O., Wejde, J., Folpe, A. L., Nord, K. H., & Mertens, F. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31827ae13b · Cited by 50
FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing’s sarcoma cells
Yang, L., Hu, H., Zielinska‐Kwiatkowska, A., & Chansky, H. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.129 · Cited by 47
“This translocation results in a chimeric transcript encoding the N-terminal domain of the RNA-binding protein EWS and the DNAbinding domain of the ETS family transcription factor Fli1 [2].”
BackgroundSelective expression of erg isoforms in human endothelial cells
Hewett, P. W., Nishi, K., Daft, E. L., & Murray, J. C. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00022-x · Cited by 47
STAT3 is activated in a subset of the Ewing sarcoma family of tumours
Lai, R. L., Navid, F., Galindo, C. R., Liu, T., Fuller, C., Ganti, R., Dien, J., Dalton, J., Billups, C. A., & Khoury, J. (2006) · The Journal of Pathology · doi:10.1002/path.1941 · Cited by 58
“The most frequent of these EWS/Ets translocations is t(11;22)(q24;q12), which leads to inframe fusion of EWS at 22q12 to FLI1 at 11q24 and the formation of EWS–FLI1 on der(22) [3].”
BackgroundEvans, C. H., Liu, F., Porter, R. M., O'Sullivan, R. P., Merghoub, T., Lunsford, E. P., Robichaud, K., van Valen, F., Lessnick, S. L., Gebhardt, M. C., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1985 · Cited by 50
“Ewing Sarcoma, and the historically named Primitive Neuroectodermal Tumor (pPNET), Biphenotypic Sarcoma and Askin’s tumor, all share recurrent translocations that involve fusion of the EWS gene (22q-12) to genes encoding ETS transcription factors, of which, fusion to the FLI-1 gene occurs in about 90% of cases (1).”
Role of Ets Transcription Factors in Mammary Gland Development and Oncogenesis
Shepherd, T. G., & Hassell, J. A. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009576801226 · Cited by 52
Allelic loss on chromosome 22Q in epithelioid sarcomas
Quezado, M., Middleton, L. P., Bryant, B. R., Lane, K., Weiss, S. W., & Merino, M. J. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)80010-5 · Cited by 47
The EWS/NOR1 Fusion Gene Product Gains a Novel Activity Affecting Pre-mRNA Splicing
Ohkura, N., Yaguchi, H., Tsukada, T., & Yamaguchi, K. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109018200 · Cited by 52
Special Article: Gene Rearrangements in Ewing's Sarcoma
Denny, C. T. (1996) · Cancer Investigation · doi:10.3109/07357909609018438 · Cited by 48
SRE elements are binding sites for the fusion protein EWS-FLI-1
Magnaghi-Jaulin, L. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.6.1052 · Cited by 47
RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites
Hollenhorst, P. C. (2012) · Small GTPases · doi:10.4161/sgtp.19630 · Cited by 52
The Ewing's sarcoma fusion protein, EWS‐FLI, binds Runx2 and blocks osteoblast differentiation
Li, X., McGee‐Lawrence, M. E., Decker, M., & Westendorf, J. J. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22782 · Cited by 46
“P values were determined with unpaired Student’s t-tests. translocation was described and shown to encode an abnormal fusion protein, EWS-FLI [Turc-Carel et al., 1988; Delattre et al., 1992].”
BackgroundMethodInfluentialEWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma
Fadul, J., Bell, R. N., Hoffman, L. M., Beckerle, M. C., Engel, M. E., & Lessnick, S. L. (2015) · Genes & Cancer · doi:10.18632/genesandcancer.57 · Cited by 47
“Translocation fusions between the various FET (FUS-EWS-TAF15) and ETS (E twenty-six) genes are the causative agent of Ewing sarcoma [1, 2].”
BackgroundAzimi, A., Tuominen, R., Svedman, F. C., Caramuta, S., Pernemalm, M., Stolt, M. F., Kanter, L., Kharaziha, P., Lehtiö, J., Johansson, C. H., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.406 · Cited by 47
Welch, D. L., Kahen, E., Fridley, B. L., Brohl, A. S., Cubitt, C. L., & Reed, D. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222228 · Cited by 46
“ES is characterized by translocations involving members of the ETS family of transcription factors, most commonly t(11;22)(q24;q12) between the amino terminus of the EWSR1 gene and the carboxy terminus of the FLI1 gene, occurring in 85–90% of cases [2, 3].”
BackgroundBCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma
Wiles, E. T., Lui, B., Bell, R. N., & Lessnick, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059369 · Cited by 49
“This tumor is characterized by a chromosomal translocation that fuses the 59 portion of the EWSR1 gene (encoding the EWS protein) on chromosome 22, in frame, to the 39 portion of the FLI1 gene (encoding the FLI protein) on chromosome 11 [2].”
BackgroundKang, H., Jenabi, J. M., Liu, X. F., Reynolds, C. P., Triche, T. J., & Sorensen, P. H. B. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0604 · Cited by 49
“EFTs are characterized by specific gene fusions involving the EWS gene on chromosome 22 and erythroblastosis-26 (ETS)related genes such as FLI1 on chromosome 11 (23) or ERG on chromosome 21 (24).”
BackgroundGENETICS OF SOFT TISSUE TUMORS
van de Rijn, M., & Fletcher, J. A. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100052 · Cited by 50
Shorter, J., & Taylor, J. P. (2013) · Rare Diseases · doi:10.4161/rdis.25200 · Cited by 53
Sanalkumar, R., Dong, R., Lee, L., Xing, Y., Iyer, S., Letovanec, I., Rosa, S. L., Finzi, G., Musolino, E., Papait, R., et al. (2023) · Science Advances · doi:10.1126/sciadv.abo3789 · Cited by 43
“EWS-FLI1 is recognized as the main oncogenic driver of this malignancy and has been shown to behave as a powerful aberrant TF that remodels the epigenetic landscape of permissive cells, resulting in their transformation ( 35 – 38 ).”
Thomsen, C., Grundevik, P., Elias, P., Ståhlberg, A., & Åman, P. (2013) · The FASEB Journal · doi:10.1096/fj.13-234435 · Cited by 46
Lamhamedi-Cherradi, S.-E., Menegaz, B. A., Ramamoorthy, V., Aiyer, R. A., Maywald, R. L., Buford, A. S., Doolittle, D. K., Culotta, K. S., O'Dorisio, J. E., & Ludwig, J. A. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0334 · Cited by 45
“17), FEV1 (18), or ZSG (19), which jointly represent less than 5%of the cases (20, 21).”
BackgroundHorvai, A., Kramer, M. J., & O’Donnell, R. J. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-792-cnecwc · Cited by 45
Ewing’s sarcoma origin: from duel to duality
Riggi, N., Suvà, M.-L., & Stamenkovic, I. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.81 · Cited by 45
Melanotic Neuroectodermal Tumor of Infancy: A Molecular Genetic Study
Khoddami, M., Squire, J. A., Zieleńska, M., & Thorner, P. S. (1998) · Pediatric and Developmental Pathology · doi:10.1007/s100249900042 · Cited by 45
“Detection of the translocations t(11;22)(q24;q12) characteristic of Ewing sarcoma and pPNET and t(11;22)(p13;q12) characteristic of DSRCT was done by reverse transcriptase polymerase chain reaction (RT-PCR) based on reported primer sequences [14,21] following the protocol as previously reported [22].”
MethodMicrosatellites are EWS/FLI response elements: Genomic "junk" is EWS/FLI's treasure
Gangwal, K., & Lessnick, S. L. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6892 · Cited by 45
Thiel, U., Wawer, A., Wolf, P., Badoglio, M., Santucci, A., Klingebiel, T. E., Basu, O., Borkhardt, A., Laws, H.-J., Kodera, Y., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq703 · Cited by 45
“They are defined by the expression of a chimeric transcript, commonly deriving from the reciprocal translocation t(11;22)(q24;q12) that results in formation of an EWS/ETS fusion gene, whose detection permits a specific molecular genetic diagnosis [6, 7].”
BackgroundSilvany, R. E., Eliazer, S., Wolff, N. C., & Ilaria, R. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203811 · Cited by 55
“EWS belongs to a family of RNA-binding proteins possessing transcriptional activation ability (Bertolotti et al., 1998; Lessnick et al., 1995; Ohno et al., 1993, 1994) and FLI-1 is a member of the ETS family of DNAbinding proteins (Delattre et al., 1992).”
BackgroundThe Ews-ERG Fusion Protein Can Initiate Neoplasia from Lineage-Committed Haematopoietic Cells
Codrington, R., Pannell, R., Forster, A. M., Drynan, L. F., Daser, A., Lobato, N., Metzler, M., & Rabbitts, T. H. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030242 · Cited by 46
“The EWS gene, at Chromosome 22 band q12, was first identified in Ewing’s sarcoma by its association with FLI1 and ATF1 [16,17] and subsequently found in subsets of Ewing’s sarcoma with either ERG or ETV1, and E1AF and FEV [17–21].”
BackgroundDirect regulation of BCL‐2 by FLI‐1 is involved in the survival of FLI‐1‐transformed erythroblasts
Lesault, I., Quang, C. T., Frampton, J., & Ghysdael, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.694 · Cited by 46
Ewing sarcoma from molecular biology to the clinic
Dupuy, M., Lamoureux, F., Mullard, M., Postec, A., Regnier, L., Baud’huin, M., Georges, S., Royer, B. B.-L., Ory, B., Rédiní, F., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1248753 · Cited by 53
Amaral, A. T., Garofalo, C., Frapolli, R., Manara, M. C., Mancarella, C., Uboldi, S., Giandomenico, S. D., Ordóñez, J. L., Sevillano, V., Malaguarnera, R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1688 · Cited by 44
“22 EWS is characterized by the presence of balanced translocations, in which over 90% of cases 23 present EWS-FLI1 fusion (EWS-FLI1 type 1, 2 or 3 chimeras depending on the exons involved) 24 (13).”
BackgroundWnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors
Pridgeon, M. G., Grohar, P. J., Steensma, M. R., & Williams, B. O. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0377-9 · Cited by 48
Dermatofibrosarcoma Protuberans Harboring t(9;22)(q32;q12.2)
Sonobe, H., Furihata, M., Iwata, J., Ohtsuki, Y., Chikazawa, M., Taguchi, T., & Shimizu, K. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00183-6 · Cited by 44
“The region around 22q12 includes various tumorrelated genes, such as EWS [20] and NF2 [21].”
BackgroundRNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1
Erkizan, H. V., Schneider, J. A., Sajwan, K. P., Graham, G. T., Griffin, B. L., Chasovskikh, S., Youbi, S. E., Kallarakal, A. T., Chruszcz, M., Padmanabhan, R., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1328 · Cited by 45
“These results challenge a current paradigm of EWS-FLI1 as strictly a DNA-binding protein; since the RNA-binding domain of EWS is lost in the translocation and FLI1 has never been described as binding to RNA (74).”
ResultSarrazin, S., Starck, J., Gonnet, C., Doubeikovski, A., Mélet, F., & Morlé, F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.2959-2969.2000 · Cited by 48
“The Fli-1 gene also is rearranged in a majority of cases of the Ewing family of tumors that share t(11;22) chromosome translocation (8).”
BackgroundIdentification of Target Genes in Their Native Cellular Context
Owen, L. A., & Lessnick, S. L. (2006) · Cell Cycle · doi:10.4161/cc.5.18.3213 · Cited by 45
Biology of EWS/FLI and Related Fusion Genesin Ewing’s Sarcoma and Primitive Neuroectodermal Tumor
May, W. A., & Denny, C. T. (1997) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60479-9_9 · Cited by 52
Zis: a developmentally regulated gene expressed in juxtaglomerular cells
Karginova, E. A., Pentz, E. S., Kazakova, I. G., Norwood, V. F., Carey, R. M., & Gómez, R. A. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.5.f731 · Cited by 44
Laake, K., Ødegård, Å., Andersen, T. I., Bukholm, I. K., Kåresen, R., Nesland, J. M., Ottestad, L., Shiloh, Y., & Børresen‐Dale, A. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199703)18:3<175::aid-gcc4>3.3.co;2-r · Cited by 70
Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion
Sadri, N., Barroeta, J. E., Pack, S., Abdullaev, Z., Chatterjee, B., Raghunath, P. N., Brooks, J. S., Barr, F. G., & Zhang, P. J. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1613-7 · Cited by 45
“In 85 to 90 % of cases, the translocation is t(11;22)(q24;q12) resulting in EWSR1-FLI1 fusion gene [2, 3].”
BackgroundOncostatin M Is a Growth Factor for Ewing Sarcoma
David, E., Tirode, F., Baud’huin, M., Guihard, P. J., Laud, K., Delattre, O., Heymann, M., Heymann, D., Rédiní, F., & Blanchard, F. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.07.023 · Cited by 43
Self-citationTranscription factor defects causing platelet disorders
Daly, M. E. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.07.002 · Cited by 51
“leads to Ewings sarcoma [104].”
USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth
Gierisch, M. E., Pedot, G., Walser, F., Lopez-Garcia, L. A., Jaaks, P., Niggli, F. K., & Schäfer, B. W. (2019) · Scientific Reports · doi:10.1038/s41598-018-37264-5 · Cited by 44
Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
Schmidt, O., Nehls, N., Prexler, C., von Heyking, K., Groll, T., Pardon, K., García, H. D., Hensel, T., Gürgen, D., Henssen, A. G., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02125-z · Cited by 51
Vibert, J., Saulnier, O., Collin, C., Petit, F., Borgman, K. J. E., Vigneau, J., Gautier, M., Zaïdi, S., Pierron, G., Watson, S., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.019 · Cited by 45
Self-citationSex-lethal Interactions with Protein and RNA
Wang, J., Dong, Z., & Bell, L. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22227 · Cited by 43
Targeting the p53 Pathway in Ewing Sarcoma
Neilsen, P. M., Pishas, K. I., Callen, D. F., & Thomas, D. M. (2010) · Sarcoma · doi:10.1155/2011/746939 · Cited by 50
“Ewing Sarcoma EWS-FLI1 t(11;22)(q24;q12) [73]”
BackgroundWinter, G. E., Rix, U., Lissat, A., Stukalov, A., Müllner, M. K., Bennett, K. L., Colinge, J., Nijman, S. M. B., Kubicek, S., Kovar, H., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0100 · Cited by 43
“At the molecular level, Ewing’s sarcoma is defined by a chromosomal translocation, such as t(11;22)(q24;q12), which accounts for approximately 85% of all cases and which results in the translation of the aberrant gene product EWS-FLI1 (5).”
BackgroundSelf-citationFusion of the EWS Gene to a DNA segment from 9q22‐31 in a human myxoid chondrosarcoma
Gill, S., McManus, A. P., Crew, A. J., Benjamin, H., Sheer, D., Gusterson, B. A., Pinkerton, R., Patel, K., Cooper, D. C. S., & SHIPLEY, J. M. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870120412 · Cited by 43
Characterization and Chromosomal Mapping of the HumanTFGGene Involved in Thyroid Carcinoma
Mencinger, M., Panagopoulos, I., Andreasson, P., Lassen, C., Mitelman, F., & Åman, P. (1997) · Genomics · doi:10.1006/geno.1997.4625 · Cited by 43
Similar outcome of elderly patients in Intergroup Trial 0096
Yuen, A. R., Zou, G., Turrisi, A. T., Sause, W. T., Komaki, R. R., Wagner, H., Aisner, S. C., Livingston, R. B., Blum, R. H., & Johnson, D. H. (2000) · Cancer · doi:10.1002/1097-0142(20001101)89:9<2006::aid-cncr18>3.0.co;2-7 · Cited by 140
Amplified, lost, and fused genes in 11q23–25 amplicon in acute myeloid leukemia, an array‐CGH study
Tyybäkinoja, A., Saarinen‐Pihkala, U. M., Elonen, E., & Knuutila, S. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20288 · Cited by 43
“It forms a fusion gene with EWSR1 after translocation in Ewing’s sarcoma (Delattre et al., 1992; May et al., 1993).”
BackgroundNew directions in molecular medicine.
Karp, J. E., & Broder, S. (1994) · PubMed · Cited by 43
Cidre‐Aranaz, F., Grünewald, T. G. P., Surdez, D., García‐García, L., Lázaro, J. C., Kirchner, T., González‐González, L., Sastre, A., García‐Miguel, P., López-Pérez, S. E., et al. (2016) · Oncogene · doi:10.1038/onc.2016.244 · Cited by 46
Self-citationPerry, J. A., Seong, B. K. A., & Stegmaier, K. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055710 · Cited by 42
“…a reciprocal translocation at t(11;22)(q24;q12) was first characterized in Ewing sarcoma in the mid-1980s (Turc-Carel et al. 1984), the oncogenic fusion protein created by that translocation and its significance were not characterized molecularly until almost a decade later (Delattre et al. 1992).”
BackgroundMiller, H. E., Gorthi, A., Bassani, N., Lawrence, L. A., Iskra, B. S., & Bishop, A. J. R. (2020) · Cancers · doi:10.3390/cancers12040948 · Cited by 45
“Ewing sarcoma is an aggressive cancer of the bone and soft tissues resulting from the fusion of Ewing sarcoma RNA Binding Protein 1 (EWSR1) to Friend leukemia integration 1 transcription factor (FLI1) (85%) or E-twenty-six-related (ETS-related) gene (ERG) (15%) [1].”
BackgroundEWS is a substrate of type I protein arginine methyltransferase, PRMT8
Kim, S. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000024 · Cited by 42
“neuro-ectodermal tumors (PNET) (1,2).”
Pahlich, S., Bschir, K., Chiavi, C., Belyanskaya, L. L., & Gehring, H. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20579 · Cited by 42
Guipaud, O., Guillonneau, F., Labas, V., Praseuth, D., Rossier, J., López, B. S., & Bertrand, P. (2006) · PROTEOMICS · doi:10.1002/pmic.200600259 · Cited by 44
Subbiah, V., Brown, R. E., Jiang, Y., Buryanek, J., Hayes-Jordan, A. A., Kurzrock, R., & Anderson, P. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068985 · Cited by 43
“ES is caused by the translocation of the EWSR1 gene from chromosome 22 to chromosome 11 in most cases (EWSR1-FLI1) and chromosomes 21 [8] and 7 in rare cases (EWSR1-ERG and EWSR1-ETV1) [9,10].”
BackgroundBone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
Rédiní, F., & Heymann, D. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00279 · Cited by 44
Ewing's Family of Tumors Involving Structures Related to the Central Nervous System: A Review
Hadfield, M. G., Quezado, M., Williams, R. L., & Luo, V. Y. (2000) · Pediatric and Developmental Pathology · doi:10.1007/s100249910026 · Cited by 42
ETS Family Proteins Activate Transcription from HIV-1 Long Terminal Repeat
SETH, A., HODGE, D. R., THOMPSON, D. M., ROBINSON, L., PANAYIOTAKIS, A., WATSON, D. K., & PAPAS, T. S. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1017 · Cited by 42
Shukla, N. N., Schiffman, J. D., Reed, D. R., Davis, I. J., Womer, R. B., Lessnick, S. L., & Lawlor, E. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00141 · Cited by 46
“EWSR1 TRANSLOCATION TYPE The molecular hallmark of ES is a recurrent chromosomal translocation involving the EWSR1 gene and one of several different genes belonging to the ETS family (Delattre et al., 1992).”
BackgroundXiao, X., Garbutt, C. C., Hornicek, F. J., Guo, Z., & Duan, Z. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.12.001 · Cited by 41
McBride, M. J., & Kadoch, C. (2018) · The Journal of Pathology · doi:10.1002/path.5042 · Cited by 45
“to the FLI1 gene, which encodes for an E-twenty-six (ETS) transcription factor [3].”
BackgroundGenomics and Therapeutic Vulnerabilities of Primary Bone Tumors
Scotlandi, K., Hattinger, C. M., Pellegrini, E., Gambarotti, M., & Serra, M. (2020) · Cells · doi:10.3390/cells9040968 · Cited by 45
“EWS‐FLI is the most common chimera (85% of cases) [101].”
BackgroundBoone, M. A., Taslim, C., Crow, J. C., Selich‐Anderson, J., Byrum, A. K., Showpnil, I. A., Sunkel, B. D., Wang, M., Stanton, B. Z., Theisen, E. R., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01876-5 · Cited by 42
“These tumors always contain 61 chromosomal translocations that encode fusions between a member of the FET protein family 62 and one of the ETS transcription factors (1, 3).”
InfluentialGene Duplication and Gene Fusion Are Important Drivers of Tumourigenesis during Cancer Evolution
Glenfield, C., & Innan, H. (2021) · Genes · doi:10.3390/genes12091376 · Cited by 42
Molecular Diagnosis of Ewing Tumors
Meier, V. S., Kühne, T., Jundt, G., & Gudat, F. G. (1998) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199802000-00006 · Cited by 41
Novel Secondary Somatic Mutations in Ewing's Sarcoma and Desmoplastic Small Round Cell Tumors
Jiang, Y., Subbiah, V., Jankú, F., Ludwig, J. A., Naing, A., Benjamin, R. S., Brown, R. E., Anderson, P. M., & Kurzrock, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093676 · Cited by 42
“Ewing’s sarcoma (ES) and desmoplastic small round cell tumor (DSRCT) are small cell sarcomas characterized by the translocation of chromosome 22 to chromosome 11, resulting in fusion of the EWSR1 gene to the FLI1 gene (and several rarer fusion partners) [1,2] in the case of ES (EWSR1-FLI1), and to the WT1 gene in the…”
BackgroundOrbital Ewing’s Sarcoma of the Orbit
Dutton, J. J., Rose, J. G., DeBacker, C. M., & Gayre, G. S. (2000) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/00002341-200007000-00008 · Cited by 41
Finkeltov, I., Kuhn, S. E., Glaser, T., Idelman, G., Wright, J. J., Roberts, C. T., & Werner, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205042 · Cited by 41
“Ewing's sarcoma is associated with a t(11 : 22)(q24;q12) translocation that fuses the 5' exons of the EWS gene on chromosome 22 to the 3' exons of the FLI-1 gene (Zucman et al., 1993b; Delattre et al., 1992; Jeon et al., 1995).”
BackgroundChromosomal translocations in sarcomas: prospects for therapy
Tomescu, O. A., & Barr, F. G. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02244-4 · Cited by 41
Miyazaki, Y., Boccuni, P., Mao, S. S., Zhang, J., Erdjument‐Bromage, H., Tempst, P., Kiyokawa, H., & Nimer, S. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103051200 · Cited by 42
Nozawa, S., Ohno, T., Banno, Y., Dohjima, T., Wakahara, K., Fan, D.-G., & Shimizu, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411626200 · Cited by 42
Induction of tenascin‐C by tumor‐specific EWS‐ETS fusion genes
Watanabe, G., Nishimori, H., Irifune, H., Sasaki, Y., Ishida, S., Zembutsu, H., Tanaka, T., Kawaguchi, S., Wada, T., Hata, J., et al. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10153 · Cited by 49
“In Ewing family tumors (EFTs), including Ewing sarcoma (ES) and peripheral primitive neuroectodermal tumor (PNET), the EWS-FLI1 fusion gene arises through a frequently occurring and characteristic t(11; 22) chromosomal translocation (Delattre et al., 1992).”
BackgroundHackl, W., & Lührmann, R. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0681 · Cited by 41
Translating Gene Expression Into Clinical Care: Sarcomas As a Paradigm
Nielsen, T. O., & West, R. B. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.1917 · Cited by 40
Qu, X., Yeung, C. C. S., Coleman, I. M., Nelson, P. S., & Fang, M. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.02.007 · Cited by 41
Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth
Vasileva, E., Warren, M., Triche, T. J., & Amatruda, J. F. (2022) · eLife · doi:10.7554/elife.69734 · Cited by 41
Palombo, R., Passacantilli, I., Terracciano, F., Capone, A., Matteocci, A., Tournier, S., Alberdi, A., Chiurchiù, V., Volpe, E., & Paronetto, M. P. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216042 · Cited by 43
Cui, J.-W., Vecchiarelli-Federico, L. M., Li, Y.-J., Wang, G.-J., & Ben‐David, Y. (2009) · Leukemia · doi:10.1038/leu.2009.20 · Cited by 43
Tomlins, S. A., Palanisamy, N., Brenner, J. C., Stall, J. N., Siddiqui, J., Thomas, D. G., Lucas, D. R., Chinnaiyan, A. M., & Kunju, L. P. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpn4l1bmrqpeit · Cited by 40
Knezevich, S. R., Hendson, G., Mathers, J. A., Carpenter, B. F., Lopez-Terrada, D. H., Brown, K., & Sorensen, P. H. B. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90049-1 · Cited by 43
Update on Imaging and Treatment of Ewing Sarcoma Family Tumors
Mar, W. A., Taljanovic, M. S., Bagatell, R., Graham, A. R., Speer, D. P., Hunter, T. B., & Rogers, L. F. (2008) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e31805c030f · Cited by 40
“This translocation produces the EWS/FLI-1 gene fusion in about 85% of cases and a EWS/ERG gene fusion in about 10% of cases.(44,45) These fused genes produce oncoproteins that function as transcription factors.”
BackgroundEwing sarcoma‐family tumors that arise after treatment of primary childhood cancer
Spunt, S. L., Galindo, C. R., Fuller, C. E., Harper, J. A., Krasin, M. J., Billups, C. A., & Khoury, J. D. (2006) · Cancer · doi:10.1002/cncr.21962 · Cited by 40
“The most frequent of these translocations is the t(11; 22)(q24;q12), which leads to in-frame fusion of EWS at 22q12 to FLI1 at 11q24 and the formation of the EWS-FLI1 fusion gene on der(22).(9) EWS-FLI1 modulates the expression of target genes in a sequence201”
BackgroundHistological and Molecular Evidence of Synovial Sarcoma of Bone. A Case Report*
Hiraga, H., Nojima, T., Isu, K., Yamashiro, K., Yamawaki, S., & Nagashima, K. (1999) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199904000-00014 · Cited by 40
Llombart‐Bosch, A., Pellín, A., Cardá, C., Noguera, R., Navarro, S., & Peydró-Olaya, A. (2000) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200009000-00003 · Cited by 45
“Initially, we tested for a possible fusion between the EWS and FLI1 genes using RT-PCR with primers EWS 22.8 and FLI 11.11.”
BackgroundInfluentialMolecular Genetics of Childhood Cancer: Implications for Pathogenesis, Diagnosis, and Treatment
Rubnitz, J. E., & Crist, W. (1997) · PEDIATRICS · doi:10.1542/peds.100.1.101 · Cited by 53
The genomic breakpoint and chimeric transcripts in the EWSR1–ETV4/E1AF gene fusion in Ewing sarcoma
Ishida, S., Yoshida, K., Kaneko, Y., Tanaka, Y., Sasaki, Y., Urano, F., Umezawa, A., Hata, J., & Fujinaga, K. (1998) · Cytogenetic and Genome Research · doi:10.1159/000015119 · Cited by 40
“The translocations identified to date resulted in the fusion of the N-terminal domain of EWSR1 (NTD-EWSR1) to the ETS domains of ETS family genes, thereby replacing the C-terminal RNA-binding domain of EWSR1 with the DNAbinding ETS domain (Delattre et al., 1992).”
BackgroundMethodMcManus, A. P., Gusterson, B. A., Pinkerton, R., & SHIPLEY, J. M. (1995) · The Journal of Pathology · doi:10.1002/path.1711760206 · Cited by 40
Cytogenetics and Molecular Genetics of Bone and Soft Tissue Tumors
Mandahl, N. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60860-x · Cited by 40
Krumbholz, M., Eiblwieser, J., Ranft, A., Zierk, J., Schmidkonz, C., Stütz, A. M., Peneder, P., Tomazou, E. M., Agaimy, A., Bäuerle, T., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1324 · Cited by 39
“EWSR1-FLI1 and EWSR1-ERG are the two most common fusion genes, occurring in 85% to 90% and approximately 10%, respectively (14, 15).”
BackgroundThe Role of Phase-Separated Condensates in Fusion Oncoprotein–Driven Cancers
Shirnekhi, H. K., Chandra, B., & Kriwacki, R. W. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-122050 · Cited by 39
Metadata
- Authors
- Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., Aurias, A., & Thomas, G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6391
- Pages
- 162-165
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2069351898
- Cited by
- 1,907
- References
- 30
- Citations by year
- 2026: 57 · 2025: 72 · 2024: 69 · 2023: 64 · 2022: 78 · 2021: 83 · 2020: 80 · 2019: 69 · 2018: 54 · 2017: 57 · 2016: 71 · 2015: 62 · 2014: 61 · 2013: 63 · 2012: 45
- FWCI
- 60.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- Ewing sarcoma, primitive neuroectodermal tumor, 22)(q24, EWSR1, gene fusion, chromosomal translocation, RNA-binding domain
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, Gene Frequency, Humans, Molecular Sequence Data, Nucleic Acid Hybridization, Sarcoma, Ewing, Sequence Homology, Nucleic Acid, Transcription, Genetic, Translocation, Genetic, Restriction Mapping, DNA Probes, Polymerase Chain Reaction, Open Reading Frames, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.